SyntheticMR AB
develops and markets innovative software solutions for Magnetic Resonance Imaging (MRI). SyntheticMR AB has developed SyMRI®, delivering multiple, adjustable contrast images and quantitative data from one 5-6 minutes scan. SyMRI is available in three different packages. SyMRI IMAGE provides fast MRI workflows, allowing high patient throughput. SyMRI NEURO enables automatic segmentation of brain tissue, providing objective decision support. SyMRI Research Edition includes exportable SyMaps™, parametric T1, T2 and PD maps of the brain, allowing the investigation to be taken even further. SyMRI is CE-marked product. SyMRI is FDA 510(k) pending. SyMRI is a registered trademark in Europe and in the USA. SyntheticMR is listed on the AktieTorget exchange in Stockholm, Sweden. www.syntheticmr.comAbout Us Technology Products Clinical Studies Investors Press & News Working Here Contact

© 2013-2017 SyntheticMR AB | All rights reserved | Address: Storgatan 11, 582 23 Linköping, SE Sweden, E-mail: info@syntheticmr.com

xhtml 1.0plucerawebbyrå

SyntheticMR AB published this content on 23 January 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 23 January 2017 09:00:07 UTC.

Original documenthttp://www.syntheticmr.com/press-news/news/umea-university-method-to-measure-changes-in-the-brain-due-to-multiple-sclerosis-ms-studied/

Public permalinkhttp://www.publicnow.com/view/52E57922C1C46D2317FF659AC8515C35B1D27B4F